Abstract
Background
Exercise is the only established disease-modifying intervention in Parkinson's disease (PD), and continued exploration of innovative and engaging exercise modalities may further enhance outcomes for individuals living with PD. Table tennis (TT) is a cognitively engaging, task-specific activity integrating visuospatial processing, anticipatory motor planning, and dynamic postural control.
Objective
To examine the feasibility, including attendance, retention, and safety, and effects of a 12 week TT-based program, NeuroPongTM, on motor and non-motor symptoms in individuals with PD.
Methods
In this single-arm pilot study, 30 participants were enrolled and 26 completed 12 weeks of twice-weekly, 2-h TT sessions. The primary outcome was the Movement Disorders Society-Unified Parkinson's Disease Rating Scale Part III (MDS-UPDRS III). Secondary outcomes included the Berg Balance Scale (BBS), Timed Up and Go (TUG), Six-Minute Walk Test (6MWT), Montreal Cognitive Assessment (MoCA) and several patient-reported outcomes. Pre-post comparisons were conducted using paired T-tests.
Results
Improvements were observed in the MDS-UPDRS Part III (mean change −5.73, 95% CI −9.02 to −2.44, p = 0.0014), BBS (mean change +3.08, 95% CI 1.987 to 4.17, p < 0.0001), TUG (mean change −1.04, 95% CI
Conclusions
A 12-week TT-based program, NeuroPong™, was feasible and associated with improvement in motor function, balance, walking endurance and self-reported depression in PD. The multidimensional motor and cognitive demands of table tennis may contribute to these observed benefits. Larger randomized controlled trials are warranted.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
